Substantial evidence has demonstrated a role for the Notch gene family in multiple human cancers, including neoplasms of the lymphoid system, pancreas, breast and CMS, among others. However, the pathophysiological mechanism of Notch function remains poorly understood. The underlying hypothesis of this proposal is that deregulation of the Notch signal transduction pathway drives the neoplastic conversion of cells, playing an important role in both the initiation and maintenance of the transformed state. This transforming activity is an intrinsic property of Notch and Notch mediates its effects through a signaling complex(s). My laboratory has developed in vitro strategies to study the mechanism of action of the mammalian Notch signal transduction pathway in the neoplastic transformation of cells. Research proposed herein is designed to seek a better understanding of the molecular nature of Notch and how activation of Notch subverts the normal physiology of the cell and deregulates growth controls.
Specific aims for this proposal include; structure and function analysis of Notch, characterization of the Notch signaling complex, mechanism of cell cycle regulation and regulation of gene expression by Notch. The long-range goal for these studies is to obtain a comprehensive understanding of how Notch activity transforms cells in order to contribute to the rational design of cancer therapeutics.
|Li, Bin; Orton, Darren; Neitzel, Leif R et al. (2017) Differential abundance of CK1? provides selectivity for pharmacological CK1? activators to target WNT-dependent tumors. Sci Signal 10:|
|Han, Xiaoqing; Ranganathan, Prathibha; Tzimas, Christos et al. (2017) Notch Represses Transcription by PRC2 Recruitment to the Ternary Complex. Mol Cancer Res 15:1173-1183|
|Broadus, Matthew R; Chen, Tony W; Neitzel, Leif R et al. (2016) Identification of a Paralog-Specific Notch1 Intracellular Domain Degron. Cell Rep 15:1920-9|
|Astudillo, Luisana; Da Silva, Thiago G; Wang, Zhiqiang et al. (2016) The Small Molecule IMR-1 Inhibits the Notch Transcriptional Activation Complex to Suppress Tumorigenesis. Cancer Res 76:3593-603|
|Weaver, Kelly L; Alves-Guerra, Marie-Clotilde; Jin, Ke et al. (2014) NACK is an integral component of the Notch transcriptional activation complex and is critical for development and tumorigenesis. Cancer Res 74:4741-51|
|Bai, Feng; Chan, Ho Lam; Scott, Alexandria et al. (2014) BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor development. Cancer Res 74:6161-72|
|Wang, Zhiqiang; Da Silva, Thiago G; Jin, Ke et al. (2014) Notch signaling drives stemness and tumorigenicity of esophageal adenocarcinoma. Cancer Res 74:6364-74|
|Azzam, Diana J; Zhao, Dekuang; Sun, Jun et al. (2013) Triple negative breast cancer initiating cell subsets differ in functional and molecular characteristics and in ?-secretase inhibitor drug responses. EMBO Mol Med 5:1502-22|
|Licciulli, Silvia; Avila, Jacqueline L; Hanlon, Linda et al. (2013) Notch1 is required for Kras-induced lung adenocarcinoma and controls tumor cell survival via p53. Cancer Res 73:5974-84|
|Fei, Dennis Liang; Sanchez-Mejias, Avencia; Wang, Zhiqiang et al. (2012) Hedgehog signaling regulates bladder cancer growth and tumorigenicity. Cancer Res 72:4449-58|
Showing the most recent 10 out of 25 publications